And bone marrow is actually what we use to save the lives of tens of thousands of patients, most of whom have advanced malignancies like leukemia and lymphoma and some other diseases.

And, really, this is the fourth of these molecules to kind of graduate from our little pipeline of drug discovery, two of which a topical drug for lymphoma of the skin and an oral substance for the treatment of multiple myeloma will actually come to the bedside for the first clinical trial in July of this year for us, a major and exciting milestone.